At the 2026 Octane Aesthetics Tech Forum, Johnny Franco, MD, FACS, of Austin Plastic Surgeon, called 2026 the “year of the regenerative revolution,” disclosed he is excited to see the weight loss medication, Retatrutide (Triple G), hit the market, and combination treatments he implemented in his practice for patients on GLP-1 RAs.
advertisement
Octane Aesthetics Tech Forum: What is Next for GLP-1 RAs and Aesthetic Innovation
Share
Save
Restart
Resume
Share this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Presenters
Recommended
Details
Presenters
Overview
At the 2026 Octane Aesthetics Tech Forum, Johnny Franco, MD, FACS, of Austin Plastic Surgeon, called 2026 the “year of the regenerative revolution,” disclosed he is excited to see the weight loss medication, Retatrutide (Triple G), hit the market, and combination treatments he implemented in his practice for patients on GLP-1 RAs.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
advertisement
Recommended
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?